B7.1/IL-2 Leukaemia Cell Vaccine for Non-Transplant AML RFUSIN2-AML2 (NTX)

Clinical trial NCT02493829 · UNKNOWN

Trial details

NCT number: NCT02493829
Sponsor: King's College London
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Leukemia, Myeloid, Acute Myelodysplastic Syndromes

Start date: 2017-05-01
Primary completion: 2020-05-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.